Top holdings
Holding types
Countries
Sectors
Analyst ratings
Market Data
Dividend
If you've tuned into the many ongoing discussions about the future of artificial intelligence (AI), you may have encountered an interesting idea as it pertains to cryptocurrency investments. In short, so the idea goes, the AI agents of the very near future may have a need to hold resources and transact with each other, and to do that, cryptocurrencies are the obvious way that they'll prefer (or be coded) to do it.
MUNICH, Germany--(BUSINESS WIRE)--Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced promising topline data from the completed Phase 1 clinical trial of its lead mRNA therapeutic candidate, ETH47, in healthy volunteers. Designed to address the upstream trigger of asthma exacerbations, ETH47 encodes interferon lambda (IFNλ), a protein essential for viral immunity in the respiratory tract. These topline results provide the first.
FAQ
- What is ETH ETF?
- Does ETH pay dividends?
- What is the current assets under management for ETH?
- What is ETH average volume?
- What is ETH inception date?